(Q34355411)

1 August 2017

title

Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein (English)

1 reference

1 August 2017

0 references

1 reference

Vijaylaxmi Grey

1

1 reference

1 August 2017

Shawn R Mohammed

2

1 reference

1 August 2017

Argyrios A Smountas

3

1 reference

1 August 2017

Rasha Bahlool

4

1 reference

1 August 2017

Larry C Lands

5

1 reference

1 August 2017

publication date

1 December 2003

1 reference

Journal of Cystic Fibrosis

1 August 2017

published in

1 reference

1 August 2017

volume

2

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

195-198

1 reference

Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Albumin-mediated regulation of cellular glutathione and nuclear factor kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Lymphocyte glutathione levels in children with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Effect of supplementation with a cysteine donor on muscular performance

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Glutathione metabolism in the lung: inhibition of its synthesis leads to lamellar body and mitochondrial defects

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Comparison of three techniques for body composition analysis in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Glutathione biosynthesis and its inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Pulmonary oxidative stress response in young children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Effect of high-dose ibuprofen in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

The level and half-life of glutathione in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900097-3

7 January 2021

10.1016/S1569-1993(03)00097-3

Identifiers

DOI

1 reference

1 August 2017

1 reference